Searched for
MAYNE PHARMA INTERNATIONAL PTY LTD
Pakistan court sentences 4 leaders of Imran Khan's party to 10-year jail, former FM Qureshi acquittedA Pakistan court has handed down 10-year sentences to four senior leaders of Imran Khan's party for their involvement in the 2023 riots, th...- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Air India Express set to open bookings for inaugural international flight to Abu DhabiAir India Express is poised to launch international flights from the new Navi Mumbai Airport to Abu Dhabi on July 15, marking a significant...
- PPL India gets statutory backing for licensing sound recording rightsPhonographic Performance (PPL India), representing over 500 music labels, has officially received registration as a copyright society under...
- International Yoga Day 2026: Theme, significance, history and celebrationsInternational Yoga Day 2026, on June 21, champions "Yoga for Healthy Ageing," highlighting yoga's role in promoting longevity and well-bein...
- Debit operations of 3 bank accounts of TMC holding Rs 440 cr frozenKolkata's Trinamool Congress faces a financial crisis as three party accounts, holding approximately Rs 440 crore, have been frozen. Rebel ...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- India, Uzbekistan aim to double bilateral trade in 3 yearsIndia and Uzbekistan are set to significantly boost bilateral trade, aiming to double it within three years. Discussions at the recent Inte...
- 'Ready to quit as chief if no faith in me': Uddhav Thackeray rejects Congress merger claimsAmidst a fresh rebellion, Shiv Sena (UBT) chief Uddhav Thackeray emotionally offered to step down if workers lost faith in his leadership. ...
- BCCI keeps 2027 World Cup roadmap under wraps, says SaikiaBCCI secretary Devajit Saikia has stated that discussions regarding India's 2027 World Cup plans are confidential. He emphasized that strat...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
- Fuel prices in India won't fall immediately despite global crude slump, MoS Suresh Gopi reveals whyUnion Minister Suresh Gopi explained that immediate fuel price reductions aren't possible despite global crude cost drops due to transit ti...
- Navi Mumbai International Airport to launch international flights from July 15Navi Mumbai International Airport (NMIA) is set to launch international passenger and cargo freighter services on July 15, pending final re...
- DS Group to hike investment in hospitality segment to Rs 1,500 cr: Vice-Chairman Rajiv KumarDS Group is boosting its hospitality investment to Rs 1,500 crore. The conglomerate plans to double its room count ahead of its 2029 target...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
